Physician profile
Ben E Leff
NPI 1699766303
$1,051.78
in general payments reported to CMS, 2019-2025
16 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $238 · 2021: $74.15 · 2022: $66.91 · 2023: $29.29 · 2024: $203 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $199.56 | 2019-2025 | Audion Et Dilation System |
| Genzyme Corporation | $165.49 | 2022-2025 | |
| Smith+Nephew, INC. | $126.30 | 2020-2024 | Tula, Halo |
| Glaxosmithkline, LLC. | $121.42 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $102.16 | 2024-2025 | Dupixent |
| Aerin Medical INC. | $78.03 | 2024 | |
| Baxter Healthcare | $49.23 | 2019 | |
| Agiliti Surgical, INC. | $37.97 | 2022 | |
| Intersect Ent, INC. | $29.13 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.40 | 2025 | Keytruda |
| Celgene Corporation | $26.29 | 2022-2023 | Zeposia |
| Acell, INC. | $21.34 | 2019 | |
| Davol INC. | $21.33 | 2021 | |
| Biotissue Holdings INC. | $16.39 | 2021 | |
| Integra Lifesciences Corporation | $15.96 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.78 | 2025 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Leff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.